CAS: 2377634-39-2

IUPAC: 4-[[2-(Diethylamino)ethoxy]methyl]-2,3-dimethoxybenzenamine

Chemical Formula: C15H26N2O3

Molecular Weight: 240.23282.38

H-NMR and C-NMR are provided upon request.

All chemicals supplied by Captis Biotech are intended exclusively for research purposes and are not suitable for human consumption. Purchasers must be affiliated with an industry or academic institution and must provide verifiable proof of affiliation prior to purchase approval.

EB3017 (5 mg)

Name: EB3017 (5 mg)
SKU: 0000113

SKU: 0000113

$250.00

Quantity

This compound is part of a focused library for the development of drugs for the treatment of CPVT (Catecholaminergic Polymorphic Ventricular Tachycardia) and other related cardiovascular diseases. This library contains compounds with different scaffolds that incorporate structural features associated with RyR2 inhibitory activity.
Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.

NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN CAPTIS BIOTECHNOLOGY'S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN CAPTIS BIOTECHNOLOGY AND BUYER, CAPTIS BIOTECHNOLOGY SELLS THIS PRODUCT AS-IS AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.

EB3017 (5 mg)

Product Info

Return

Shipping

References:

Storage